In 2004 a patient with both AAT deficiency (MZ) and severe fibromyalgia/CFS (Chronic Fatigue Syndrome) participated in a trial with AAT-intravenous augmentation therapy after the failure of conventional therapies. The gene discussed is SERPINA1; the disease is fibromyalgia.